Medpace Holdings (MEDP) EBT Margin (2015 - 2026)
Medpace Holdings' (MEDP) quarterly EBT Margin came in at 21.44% in Q2 2026, up 80.0% on a YoY basis from 11.91% in Q2 2025, and up 2.65% quarter-over-quarter from 20.89% in Q1 2026.
Powered by 
Analysis
Medpace Holdings (MEDP) EBT Margin (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported EBT Margin for 12 consecutive years, with 21.44% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 80.0% year-over-year to 21.44%; the trailing twelve-month figure through Jun 2026 stood at 21.53% (down 67.0% YoY), and the FY2025 full-year result was 21.44%, down 113.0% from the prior year.
- EBT Margin improved to 21.44% in Q2 2026 per MEDP's latest filing, from 20.89% in the prior quarter.
- Across five years, EBT Margin topped out at 24.95% in Q4 2024 and bottomed at 16.44% in Q2 2023.
- Historically, EBT Margin has averaged 20.38% across 5 years, with a median of 20.9% in 2024.
- The sharpest annual moves came in 2023 and 2024: EBT Margin tumbled 445 bps in 2023, then soared 675 bps in 2024.
- Over 5 years, EBT Margin stood at 18.69% in 2022, then decreased by 3 bps to 18.2% in 2023, then surged by 37 bps to 24.95% in 2024, then decreased by 11 bps to 22.14% in 2025, then decreased by 3 bps to 21.44% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 21.44%, 20.89%, and 22.14% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 6.89% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 21.44% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 4.47% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 5.30% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -0.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -283.75% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.72% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -159,859.15% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,194.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.44% |
| Mar 31, 2026 | 20.89% |
| Dec 31, 2025 | 22.14% |
| Sep 30, 2025 | 21.64% |
| Jun 30, 2025 | 20.64% |
| Mar 31, 2025 | 21.16% |
| Dec 31, 2024 | 24.95% |
| Sep 30, 2024 | 22.27% |
| Jun 30, 2024 | 20.92% |
| Mar 31, 2024 | 22.07% |
| Dec 31, 2023 | 18.20% |
| Sep 30, 2023 | 16.89% |
| Jun 30, 2023 | 16.44% |
| Mar 31, 2023 | 19.82% |
| Dec 31, 2022 | 18.69% |
| Sep 30, 2022 | 21.34% |
| Jun 30, 2022 | 17.65% |
| Mar 31, 2022 | 19.74% |
| Dec 31, 2021 | 18.12% |
| Sep 30, 2021 | 18.52% |